[Federal Register Volume 77, Number 36 (Thursday, February 23, 2012)]
[Notices]
[Page 10758]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-4212]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Submission for OMB Review; Comment Request; Application for 
Collaboration With the NIH Center for Translational Therapeutics (NCTT)

SUMMARY: Under the provisions of Section 3507(a)(1)(D) of the Paperwork 
Reduction Act of 1995, the National Center for Advancing Translational 
Sciences (NCATS), the National Institutes of Health (NIH) has submitted 
to the Office of Management and Budget (OMB) a request for review and 
approval of the information collection listed below. This proposed 
information collection was previously published in the Federal Register 
on November 11, 2011, page 69743-69744 and allowed 60-days for public 
comment. No public comments were received. The purpose of this notice 
is to allow an additional 30 days for public comment. The National 
Institutes of Health may not conduct or sponsor, and the respondent is 
not required to respond to, an information collection that has been 
extended, revised, or implemented on or after October 1, 1995, unless 
it displays a currently valid OMB control number.
    Proposed Collection: Title: Application for collaboration with the 
NIH Center for Translational Therapeutics (NCTT) . Type of Information 
Collection Request: New. Need and Use of Information Collection: 
Programs at the NCTT provide opportunities to partner with and gain 
access to both common and specifically rare and neglected disease 
through a variety of programs delivering assay development, screening, 
hit to lead chemistry, lead optimization, chemical biology studies, 
drug development capabilities, expertise, and clinical/regulatory 
resources in a collaborative environment with the goal of moving 
promising therapeutics into human clinical trials. NCTT uses an 
application and evaluation process to select collaborators. Selected 
investigators provide the drug project starting points and ongoing 
biological/disease expertise throughout the project. Frequency of 
Response: Once per year. Affected Public: Research scientists. Type of 
Respondents: not-for-profits, for-profit, governmental. The annual 
reporting burden is as follows: Estimated Number of Respondents: 170. 
Estimated Number of Responses per Respondent: 1. Average Burden Hours 
Per Response: 1. Estimated Total Annual Burden Hours Requested: 510.

                                            Estimates of Hour Burden
----------------------------------------------------------------------------------------------------------------
                                                                Number of      Average burden
                  Forms                       Number of       responses per       hours per       Total annual
                                             respondents       respondent         response        burden hours
----------------------------------------------------------------------------------------------------------------
Online Collaborator Solicitation........               170                 1                 1               170
NCTT Project Information Template.......               170                 1                 1               170
Solicitation Instructions (TRND)........               100                 1                 1               100
Solicitation Instructions (BrIDGs)......                70                 1                 1                70
�����������������������������������������
    Total...............................  ................  ................  ................               510
----------------------------------------------------------------------------------------------------------------

    The annualized cost to respondents is estimated at: $21,261. 
Capital Costs are $0. Operating Cost is roughly $14,333 for the 
database to accept and coordinate responses.
    Request for Comments: Written comments and/or suggestions from the 
public and affected agencies are invited on one or more of the 
following points: (1) Whether the proposed collection of information is 
necessary for the proper performance of the function of the agency, 
including whether the information will have practical utility; (2) The 
accuracy of the agency's estimate of the burden of the proposed 
collection of information, including the validity of the methodology 
and assumptions used; (3) Ways to enhance the quality, utility, and 
clarity of the information to be collected; and (4) Ways to minimize 
the burden of the collection of information on those who are to 
respond, including the use of appropriate automated, electronic, 
mechanical, or other technological collection techniques or other forms 
of information technology.
    Direct Comments to OMB: Written comments and/or suggestions 
regarding the item(s) contained in this notice, especially regarding 
the estimated public burden and associated response time, should be 
directed to the: Office of Management and Budget, Office of Regulatory 
Affairs, <a href="/cdn-cgi/l/email-protection#226d6b70637d5157404f4b51514b4d4c624d4f400c474d520c454d54"><span class="__cf_email__" data-cfemail="f4bbbda6b5ab878196999d87879d9b9ab49b9996da919b84da939b82">[email protected]</span></a> or by fax to 202-395-6974, 
Attention: Desk Officer for NIH. To request more information on the 
proposed project or to obtain a copy of the data collection plans and 
instruments, contact: Dr. Helen Gift, Chief, Disease Prevention and 
Health Promotion Branch, DEODP, NIDCR, NIH, Natcher Building, Room 3AN-
44D, 9000 Rockville Pike, Bethesda, MD 20892, or call non-toll-free 
number 301-594-5579 or Email your request, including your address to: 
<a href="/cdn-cgi/l/email-protection#f1b6989785b9b19594c5c4df9f989583df9f9899df969e87"><span class="__cf_email__" data-cfemail="33745a55477b73575607061d5d5a57411d5d5a5b1d545c45">[email protected]</span></a>.
    Comments Due Date: Comments regarding this information collection 
are best assured of having their full effect if received within 30-days 
of the date of this publication.

    Dated: February 15, 2012.
John McKew,
Chief, Preclinical Development Branch, NIH Center for Translational 
Therapeutics, National Center for Advancing Translational Sciences, 
National Institutes of Health.
[FR Doc. 2012-4212 Filed 2-22-12; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>